(Q53947988)
Statements
A phase I trial of a potent P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), administered orally in combination with doxorubicin in patients with advanced malignancies. (English)
Eric H Rubin
Dinesh P de Alwis
Isabelle Pouliquen
Lisa Green
Phil Marder
Yong Lin
Rita Musanti
Stephanie L Grospe
Sharon L Smith
Deborah L Toppmeyer
Judy Much
Michael Kane
Ajai Chaudhary
Christopher Jordan
Michael Burgess
Christopher A Slapak
1 December 2002
8
12
3710-3717